Bayer Aktiengesellschaft (ETR:BAYN) Stock Price Down 1.3% – Here’s Why

Bayer Aktiengesellschaft (ETR:BAYN)’s stock price traded down 1.3% on Tuesday . The stock traded as low as €19.22 ($20.02) and last traded at €19.50 ($20.31). 4,583,339 shares traded hands during trading, The stock had previously closed at €19.76 ($20.58).

Bayer Aktiengesellschaft Price Performance

The stock has a market capitalization of $18.88 billion, a P/E ratio of -14.90, a PEG ratio of 36.39 and a beta of 0.97. The company has a current ratio of 1.27, a quick ratio of 0.72 and a debt-to-equity ratio of 129.94. The company has a fifty day simple moving average of €22.40 and a two-hundred day simple moving average of €25.70.

Bayer Aktiengesellschaft Company Profile

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.